Posted By Judith Volpe, MD,
Thursday, August 6, 2015
| Comments (0)
There are over 50 distinct types of autoimmune disease, in which your own immune system attacks and destroys your normal body tissues and organs. Rates of autoimmune diseases, asthma, and allergies haven increased steeply in recent decades, fueled by the ever increasing toxicity of our environment.
An autoimmune reaction is a normal body defense process gone awry. Driven by the chronic inflammation caused by constant exposure to a food allergen, chemical toxin, pathogenic microbe, etc the immune system, in its attempts to protect the system, sometimes creates antibodies [ substances meant to neutralize the offending substance ] that cross react with normal body tissues and organs. This results in a host of symptoms from fatigue and systemic inflammation to hair loss, major organ failure, and, if untreated, death.
The allopathic medical system has only one approach, and that is to suppress the immune system with toxic pharmaceuticals from corticosteroids to chemotherapy, often with serious side effects including infections and cancer. Increasingly, allopathic medicine is turning to the monoclonal antibody pharmaceuticals, commonly referred to as “the biologics” such as Humira and Enbrel. The use of these products markedly suppresses the immune system, leading to serious infections, and over time, cancers, especially lymphoma.
Alternative practitioners attempt to get to the root cause of the autoimmune reaction with intense environmental detoxification and functional medicine protocols. These approaches sometimes ameliorate the problem, and can cause remission in early cases. However, once the autoimmune reaction is set into motion, it usually can’t be undone by these methods.
What to do, then. There does exist a method of immunomodulation that is restricted to only a few physicians in the United States, and I am grateful to be one of them. It involves using “antisense peptides”, small chains of amino acids, that are capable of blocking the effects of the autoantibodies and protecting the target tissues and organs from damage. They are injected intramuscularly once every 3 or 4 weeks. Eventually, the immune system gets the message that “the war is over” and diminishes or ceases its production of autoantibodies. Thus, the disease goes into remission or is greatly ameliorated. Symptoms subside and the serum levels of autoantibodies fall. These products are remarkably safe with no major side effects in over 20 years of use. They are available, not only for autoimmune disease, but for aging [ the frail elderly ], osteoarthritis, allergies/asthma, and atherosclerosis.
Please note that these are not natural products, they are created in an immunology research institute. Proprietary restrictions mandate that detailed information regarding these products can only be discussed face-to-face in an office consultation.
LEARN MORE ABOUT JUDITH VOLPE, MD
Posted By Fiona McCulloch, ND,
Thursday, February 7, 2013
Updated: Wednesday, January 29, 2014
| Comments (0)
This article was published in the March 2011 NDNR Journal
Infertility is a reproductive disease which has an enormous impact on
the quality of life for millions of patients. It affects 1 in 5 of all
couples, and most patients undergo extensive diagnostic and treatment
interventions on their journey to create a family. Infertility has a
myriad of causes including endocrine disorders, gynecological disease,
infectious disease, circulatory disease and aging and cellular health.
Autoimmune disorders are also implicated in reproductive disorders and
may especially play a role in unexplained cases of infertility.
It is known that autoimmune diseases such as diabetes, autoimmune
thyroiditis and systemic lupus erythematosis are linked to decreased
fertility. Other causes of infertility such as premature ovarian
insufficiency, endometriosis and polycystic ovarian syndrome include
autoimmune components. In many unexplained cases of infertility,
inflammatory processes may be involved or antibodies may be directed
against hormones, clotting factors, or reproductive tissues such as the
ovaries or testes. The research into autoimmune infertility is just in
its beginning, but as naturopathic physicians there are valuable tests
and treatments we can provide to our patients who present either with
known autoimmune disorders and difficulty conceiving, or with the ever
enigmatic diagnosis of "unexplained infertility”.
The biological factors involved in autoimmune infertility are
various. These include a multitude of cellular and inflammatory changes.
Some of the most common factors are discussed below.
Endometriosis has many autoimmune components including elevated
levels of cytokines, and T- and B-cell abnormalities. Peripheral
monocytes are more active, and peritoneal macrophages are present in
higher numbers with higher activity levels. This causes increased
inflammatory cytokine release.
There are alterations in B-cell activity and an increased incidence
of autoantibodies in women with endometriosis. Like classical autoimmune
diseases, endometriosis has been associated with polyclonal B-cell
activation, immunological abnormalities in T- and B-cell functions,
increased apoptosis, tissue damage, multiorgan involvement, familial
occurrence, possible genetic basis, involvement of environmental
cofactors, and association with other autoimmune diseases. TNF-a, levels
are elevated in the peritoneal fluid of patients with endometriosis. In
women with endometriosis, TH2 mediated immunity humoral responses are
A 2001 study found that 50% of endometriosis patients had
autoantibodies to candida enolase. The same study found increased levels
of these antibodies in patients with a list of other autoimmune
Autoimmune thyroid disease and infertility.
Thyroid diseases involving antithyroid antibodies have been
correlated to infertility and increased pregnancy loss. Autoimmune
thyroid disease, even in the absence of hypothyroidism has been
associated with infertility and reduced response to fertility treatment.
It has also been associated with gluten related autoimmunity.
Autoimmune thyroid disease can lead to hypo or hyperthyroidism which can
impact fertility and cause miscarriage.
Other Autoimmune Diseases and Fertility
Antinuclear antibodies (ANAs ) which have been associated with
infertility can be present in conditions such as SLE, Sjogren’s
syndrome, Raynaud’s syndrome, and can also be detected in women with a
history of exposure to chemicals such as bisphenol-A.
Addison’s disease is associated with anti-ovarian antibodies which
can reduce ovulatory function and cause premature ovarian failure in
Patients with celiac disease may have multiple nutritional
deficiencies that can lead to infertility. Celiac disease has been
linked to recurrent miscarriage, pregnancy complication and infertility.
A 2010 study found that between 5-10% of women with a history of
stillbirth, recurrent miscarriage, intrauterine growth restriction, and
infertility were seropositive for transglutaminase IgA compared to 1% of
the control group. Latent celiac disease may be a major cause of
In approximately 20% of women with premature ovarian
insufficiency(POI), autoimmune factors can be found. POI can be linked
to autoimmune thyroid disease, Addison’s disease, or SLE or may have
unknown etiology. Women may have antibodies against the ovarian tissues,
or reproductive hormones such as FSH.
Antisperm antibodies are another cause of infertility. These can be
present in either male or female patients. They are commonly found in
males after vasectomy procedures, and their presence can make vasectomy
difficult to reverse. Antisperm antibodies affect the ability of the
sperm to penetrate the egg or reduce motility by attaching to the tail
of the sperm . They have also been associated with antiphospholipid
antibodies. Antisperm antibodies are generally produced by CD19+/5+ B
cells and are associated with elevated natural killer cells and anti-dna
Autoimmune blood clotting disorders
Disorders with increased antiphospholipid antibodies( APAs) including
anti-cardiolipin antibodies cause a hypercoagulatory state in the blood
and can be associated with reproductive failure and recurrent
miscarriage. These antibodies can be found in systemic diseases such as
SLE, or on their own.
Immunological Considerations for Patients with Reproductive Challenges
A condition of TH1 cytokine dominance can be associated with the
inability to conceive or maintain a pregnancy. In women with high
TH1/TH2 ratios there is an increased incidence of pregnancy loss and
infertility however for different autoimmune conditions the predominant
immune pathway may differ.
Natural killer(NK) cells
Elevated peripheral NK cells are associated with many systemic
autoimmune diseases but can also be found in women with unexplained
infertility conditions. NK cells produce TH1 cytokines including
TNF-alpha and Interferon gamma. These cytokines are normally involved in
cellular toxicity directed at cancerous cells and viruses . If
increased in early pregnancy, the presence of NK cells and their
cytokines can disrupt the growth and development of the embryo.
TNF-alpha works as a signal to other immune cells which then migrate to
the uterus to attack the non-self invader which has been immunologically
detected. A 1999 study found that in women who had repeated
miscarriage, there was markedly increased NK cell cytotoxicity
associated with a rise in CD56+CD16+ and a drop in CD56+ cells. Another
special type of NK cell called uterine NK (uNK) cells have a protective
immunosuppressive effect locally in the endometrium. Dysfunction of
these cells has been associated with pregnancy loss
Homocysteine and Folate Metabolism
folate deficiency and hyperhomocysteinemia are known to be risk factors
for infertility and pregnancy complications. Errors in these pathways
caused by genetic mutations have been associated with autoimmune
diseases Patients with a mutation of the MTHFR gene have difficulty
reducing 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. 5-
methyltetrahydrofolate is used to convert homocysteine to methionine by
the enzyme methionine synthase. A 2010 study on a group of 71 Swedish
and Finnish female patients with unexplained infertility found a higher
incidence of folate metabolism polymorphisms compared to women in the
general population. Folate receptor blocking autoantibodies have also
been related to subfertility
Folate metabolism disorders can can lead to reduced cell division,
inflammatory cytokine production, altered nitric oxide metabolism,
increased oxidative stress, abnormal methylation reactions and
thrombosis. This causes problems with folliculogenesis and implanting or
maintaining a healthy pregnancy. In males, defects in this pathway can
Diagnostic testing in the naturopathic clinic
In addition to general and endocrine panels for infertility, consider
testing for homocysteine, CRP, ESR, ANA panels, APA panels, PTT,
Partial PTT, DHEA-S, TSH, Antithyroglobulin, Antithyroid peroxidase,
HBA1C, CBC, diurnal cortisol, assessments for candida, and gluten
Clinically, I have found that optimal homocysteine levels should be
8mmol/L or below in patients with autoimmune infertility factors.
TH1 to TH2 ratios can be a very helpful tool for designing treatment
plans. NK assays and testing for genetic variants of MTHFR are also
These vary depending on results found and can include low dose
aspirin, anti-coagulants, corticosteroids, IVIG, Lymphocyte immunization
therapy (LIT) and TNF-alpha blockers. These are often combined with IVF
or other assisted reproductive technologies.
Treatments in the naturopathic clinic
Some of the following treatment options may be considered after a thorough assessment determines specific autoimmune factors.
- To reduce TH1 dominant inflammatory responses in patients who
require it, maritime pine extract (100mg bid), resveratrol ,(100mg bid) ,
and green tea EGCG (300mg catechins bid), . Maritime pine, and
resveratrol also inhibit platelet aggregation and thrombosis,,. The
antioxidant effects of these substances are also beneficial.
- Proline rich polypeptides such as those found in bovine colostrum
may favour a shift towards TH1 and downregulate overactive TH2
- High quality omega 3 fish oil. 2 – 3g of EPA and DHA daily to aid
with inflammatory and thrombotic disorders . A 2007 study on mice found
that a ratio of 23:14 EPA to DHA decreased tnf alpha in 8 hours. EPA
also regulates autoimmune markers in endometriosis
- L-5-methyltetrahydrofolate 5mg daily, vitamin B12 1000mcg qd and
vitamin B6 75mg qd to improve homocysteine and folate metabolism. Screen
for history of cancer before using high dose folate. Trimethylglycine
1000mg qd may also be used to lower homocysteine levels in selected
- N-Acetyl Cysteine 600mg bid. Reduces inflammatory cytokines.
Improves autoimmune thyroid disease NAC also enhances semen parameters
and the oxidative status and quality of the endometrium . NAC also
protects the integrity of ovaries subjected to physical and oxidative
damage, and aids liver detoxifcation pathways.
- For patients with thyroid antibodies, l-selenomethionine 200mcg
daily,,,. If hypothyroid, use of bio-identical hormone therapy may be
indicated to prevent miscarriage. Trace minerals for thyroid function
are also be beneficial.
- Thyroid protomorphogen may be useful for patients with antithyroid
antibodies to act as a decoy. Increase dosage slowly to 1 tablet tid.
- Elimination of gluten should be implemented as required for patients with positive serology.
- Probiotics 20 billion CFUs daily. Rotate strains monthly to modulate immunity and repair gut lining. Treat candida if present.
- Support liver detoxification pathways.
- Bio-identical progesterone is a potent immunosuppressive agent
capable of blocking both cytokine release and action . May be used in
the luteal phase of the cycle to support early pregnancy.
- DHEA – can be useful in premature ovarian insufficiency and to
improve pregnancy rate and reduce miscarriage in advanced maternal age.
It has also been found to be beneficial in the treatment of autoimmune
disease,, and to reduce NK cell activity. DHEA should only be used after
serum DHEA-S and androgen evaluation. Dose adjusted according to
patient need but is often 25mg tid or less.
- Addressing stress is very important in all patients suffering from
the effects of reproductive challenges. Autoimmune diseases are
aggravated by stress as it can increase humoral immunity and shift
TH1:TH2 ratios. Adrenal therapies, sufficient sleep, yoga, meditation,
movement therapy, and prayer can all positively effect patients in this
- Beer, A, Kantecki J, Reed J. Is your Body Baby Friendly? 1st edition. AJR Publishing 2006.
- Nothnick, WB. Treating endometriosis as an autoimmune disease. Fertility and sterility. 2001 Aug;76(2): 223-231.
- Antsiferova YS, Sotnikova NY, Posiseeva LV, Shor AL. Changes in the
T-helper cytokine profile and in lymphocyte activation at the systemic
and local levels in women with endometriosis. Fertil Steril. 2005;84(6):1705-11.
- Gitlits VM, Toh BH, Sentry JW. Disease association, origin, and
clinical relevance of autoantibodies to the glycolytic enzyme enolase. J Investig Med. 2001. 49(2):138-45.
- Kim NY, Cho HJ, Kim HY, et al. Thyroid Autoimmunity and its
Association with Cellular and Humoral Immunity in Women with
Reproductive Failures. Am J Reprod Immunol. 2011;65(1):78-87
- Ott J, Aust S, Kurz C et al. Elevated antithyroid peroxidase
antibodies indicating Hashimoto’s thyroiditis are associated with the
treatment response in infertile women with polycystic ovary syndrome. Fertility and sterility. 2010;94(7): 2895-2897.
- Guliter S, Yakaryilmaz F, Ozkurt Z, et al. Prevalence of coeliac
disease in patients with autoimmune thyroiditis in a Turkish population.
World J Gastroenterol 2007; 13(10): 1599-1601
- Geva E, Lerner-Geva L, Burke M, Vardinon N, Lessing JB, Amit A.
Undiagnosed systemic lupus erythematosus in a cohort of infertile women.
Am J Reprod Immunol. 2004;51(5):336-40.
- Kumar A, Meena M, Begum N, et al. Latent celiac disease in reproductive performance of women Fertility and sterility 24 November 2010. Epub ahead of print
- Yamada H, Atsumi T, Kato EH, et al. Prevalence of diverse
antiphospholipid antibodies in women with recurrent spontaneous
abortion. Fertil Steril. 2003;80(5):1276-1278.
- Kwak-Kim JY, Chung-Bang HS, Ng SC, et al. Increased T helper 1
cytokine responses by circulating T cells are present in women with
recurrent pregnancy losses and in infertile women with multiple
implantation failures after IVF. Human Reproduction. 2003;18(4):767-73.
- Emmer P, Nelen W, Steegers, E et al. Peripheral natural killer
cytotoxicity and CD56posCD16pos cells increase during early pregnancy in
women with a history of recurrent spontaneous abortion Hum. Reprod. (2000) 15(5): 1163-1169
- Dosiou C, and Giudice LC. Natural Killer Cells in Pregnancy and
Recurrent Pregnancy Loss: Endocrine and Immunologic Perspectives. Endocr. Rev. 2005;26(1):44-62.
- Tamura T, Picciano MF. Folate and human reproduction. Am J Clin Nutr. 2006;83:993–1016
- Mao R, Fan Y, Zuo L, et al. Association study between
methylenetetrahydrofolate reductase gene polymorphisms and Graves’
disease. Cell Biochem Funct. 2010; 28(7): 585-90.
- Brustolin S, Giugliani R, Felix TM. Genetics of homocysteine metabolism and associated disorders. Braz J Medio Res, 2010; 43(1):1-7
- Klotz L, Farkas M, Bain N, et al. The variant
methylenetetrahydrofolate reductase c.1298A>C (p.E429A) is associated
with multiple sclerosis in a German case-control study. Neurosci Lett. 2010; 468(3):183-5.
- Altmäe S, Stavreus-Evers A, Ruiz JR, et al. Variations in folate
pathway genes are associated with unexplained female infertility. Fertil Steril. 2010;94(1):130-7.
- Klotz L, Farkas M, Bain N, et al. The variant
methylenetetrahydrofolate reductase c.1298A>C (p.E429A) is associated
with multiple sclerosis in a German case-control study. Neurosci Lett. 2010; 468(3):183-5.
- Safarinejad MR, Shafiei N, Safarinejad S. Relationship Between
Genetic Polymorphisms of Methylenetetrahydrofolate Reductase (C677T,
A1298C, and G1793A) as Risk Factors for Idiopathic Male Infertility. Reprod Sci. 2010 Oct 26 [Epub ahead of print]
- Cho KJ et al. Inhibition mechanisms of bioflavonoids extracted from
the bark of Pinus maritime on the expression of pro inflammatory
cytokines. Ann NY Acad Sci. 2001;(928)141-56.
- Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M, Ravagnan G. Effects of resveratrol on human immune cell function. Life Sci. 2001; 21;70(1):81-96.
- Tian J, Gao J, Chen J, et al. Effects of resveratrol on
proliferation and apoptosis of TNF-alpha induced rheumatoid arthritis
fibroblast-like synoviocytes. Zhongguo Zhong Yao Za Zhi. 2010;35(14):1878-82.
- Zvetkova E, Wirleitner B, Tram NT, Schennach H, Fuchs D. Aqueous
extracts of Crinum latifolium (L.) and Camellia sinensis show
immunomodulatory properties in human peripheral blood mononuclear
cells. Int Immunopharmacol. 2001;1(12):2143-50.
- Gillespie K, Kodani I, Dickinson DP, et al. Effects of oral
consumption of the green tea polyphenol EGCG in a murine model for human
Sjogren’s syndrome, an autoimmune disease. Life Sci. 2008 Oct 24;83(17-18):581-8.
- Araghi-Niknam M, Hosseini S, Larson D, Rohdewald P, Watson RR. Pine bark extract reduces platelet aggregation. Integr Med. 2000 Mar 21;2(2):73-77
- Belcaro G, Cesarone MR, Rohdewald P, et al. Prevention of venous
thrombosis and thrombophlebitis in long-haul flights with pycnogenol. Clin Appl Thromb Hemost. 2004 Oct;10(4):373-7
- Olas B, Wachowicz B, Saluk-Juszczak J, Zielinski T. Effect of
resveratrol, a natural polyphenolic compound, on platelet activation
induced by endotoxin or thrombin. Thromb Res. 2002 Aug 15;107(3-4):141-5.
- Figueras M, Olivan M, Busquets S, López-Soriano FJ, Argilés JM.
Effects of Eicosapentaenoic Acid (EPA). Treatment on Insulin Sensitivity
in an Animal Model of Diabetes. Improvement of the Inflammatory Status.
Obesity (Silver Spring). 2010 Sep 30. [Epub ahead of print]
- Vanschoonbeek K, Feijge MA, Paquay M, et al. Variable hypocoagulant
effect of fish oil intake in humans: modulation of fibrinogen level and
thrombin generation. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1734-40.
- Dangardt F, Osika W, Chen Y, et al. Omega-3 fatty acid
supplementation improves vascular function and reduces inflammation in
obese adolescents. Atherosclerosis. 2010; 212(2):580-5.
- Bhattacharya A, Sun D, Rahman M, Fernandes G. Different ratios of
eicosapentaenoic and docosahexaenoic omega-3 fatty acids in commercial
fish oils differentially alter pro-inflammatory cytokines in peritoneal
macrophages from C57BL/6 female mice. J Nutr Biochem. 2007 Jan;18(1):23-30.
- Netsu S, Konno R, Odagiri K, Soma M, Fujiwara H, Suzuki M. Oral
eicosapentaenoic acid supplementation as possible therapy for
endometriosis. Fertility and sterility. 2008; (90)4: 1496-1502.
- Stanislaus R, Gilg AG, Singh AK, Singh I. N-acetyl-L-cysteine
ameliorates the inflammatory disease process in experimental autoimmune
encephalomyelitis in Lewis rats. J Autoimmune Dis. 2005 May 3;2(1):4.
- Poncin S, Colin IM, Decallonne B, et al. N-Acetylcysteine and 15
Deoxy-?12,14-Prostaglandin J2 Exert a Protective Effect Against
Autoimmune Thyroid Destruction in Vivo but Not Against
Interleukin-1a/Interferon ?-Induced Inhibitory Effects in Thyrocytes in
Vitro. The American journal of pathology. 2010;177(1)219-228
- Ciftci H, Verit A, Savas M, Yeni E, Erel O. Effects of N-acetylcysteine on semen parameters and oxidative/antioxidant status. Urology. 2009;74(1):73-6.
- Estany S, Palacio JR, Barnadas R, Sabes M, Iborra A, Martínez P.
Antioxidant activity of N-acetylcysteine, flavonoids and
alpha-tocopherol on endometrial cells in culture. J Reprod Immunol. 2007; 75(1):1-10.
- Mishra DP, Dhali A. Endotoxin induces luteal cell apoptosis through the mitochondrial pathway. Prostaglandins Other Lipid Mediat. 2007;83(1-2):75-88.
- Usta U, Inan M, Erbas H, Aydogdu N, Oz Puyan F, Altaner S. Tissue
damage in rat ovaries subjected to torsion and detorsion: effects of
L-carnitine and N-acetyl cysteine. Pediatr Surg Int. 2008; 24(5):567-73
- Zagrodzki P, Ratajczak R. Selenium supplementation in autoimmune
thyroiditis female patient–effects on thyroid and ovarian functions
(case study). Biol Trace Elem Res. 2008; 126(1-3):76-82.
- Turker O, Kumanlioglu K, Karapolat I, Dogan I. Selenium treatment in
autoimmune thyroiditis: 9-month follow-up with variable doses. J Endocrinol. 2006;190(1):151-6.
- Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. The
influence of selenium supplementation on postpartum thyroid status in
pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab. 2007;92(4):1263-8.
- Gärtner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW. Selenium
supplementation in patients with autoimmune thyroiditis decreases
thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab. 2002; 87(4):1687-91.
- Howard L. Weiner, MD. Oral tolerance for the treatement of autoimmune disease. Annual Review of Medicine. 1997; (48): 341-351.
- Raghupathy R, Al-Mutawa E, Al-Azemi M, Makhseed M, Azizieh F,
Szekeres-Bartho J. Progesterone-induced blocking factor (PIBF)
modulates cytokine production by lymphocytes from women with recurrent
miscarriage or preterm delivery. J Reprod Immunol. 2009 Jun;80(1-2):91-9
- Mamas L, Mamas E. Premature ovarian failure and dehydroepiandrosterone Fertil Steril.2009;91(2):644-646.
- Gleicher N, Ryan E, Weghofer A, Blanco-Mejia S, Barad DH.
Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in
women with diminished ovarian reserve: a case control study. Reprod Biol Endocrinol. 2009 Oct 7;7:108.
- Solerte SB, Precerutti S, Gazzaruso C, et al. Defect of a
subpopulation of natural killer immune cells in Graves’ disease and
Hashimoto’s thyroiditis: normalizing effect of dehydroepiandrosterone
sulfate. Eur J Endocrinol. 2005;152(5):703-12.
- Crosbie D, Black C, McIntyre L, Royle PL, Thomas S. Dehydroepiandrosterone for systemic lupus erythematosus. Cochrane Database Syst Rev. 2007;(4):CD005114
- Hazeldine J, Arlt W, Lord JM. Dehydroepiandrosterone as a regulator of immune cell function. J Steroid Biochem Mol Biol. 2010;120(2-3):127-36.
- Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N Y Acad Sci.2006;1069:62-76